Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Investigational New Drugs
|
January 1, 1984
Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro
B T Hill, A S Bellamy, S Metcalfe, et al.
British Journal of Urology
|
August 1, 1994
Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin
R J Popert, J Goodall, M J Coptcoat, et al.
Biochemical Pharmacology
|
February 7, 1997
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl]mitomycin C). A new mitomycin C analogue activated by serum
J R Masters, R J Know, J A Hartley, et al.
Cancer Research
|
June 1, 1988
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines
P Bedford, A M Fichtinger-Schepman, S A Shellard, et al.
British Journal of Urology
|
December 1, 1985
Serum and tissue tumour markers in seminomas
T F Ford, D N Butcher, C T Samuell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1996
Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways
J R Masters, R Thomas, A G Hall, et al.
Chemico-Biological Interactions
|
January 1, 1987
Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II)
P Bedford, M C Walker, H L Sharma, et al.
International Journal of Oncology
|
March 24, 1999
Prognostic markers in clinically localised prostate cancer
X Z Bai, J R Masters, N O'Donoghue, et al.
Oncogene
|
May 9, 2007
Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer
Q Wang, M Williamson, S Bott, et al.
European Journal of Cancer
|
March 1, 1978
Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer
J R Masters, R A Hawkins, K Sangster, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Investigational New Drugs
|
January 1, 1984
Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro
B T Hill, A S Bellamy, S Metcalfe, et al.
British Journal of Urology
|
August 1, 1994
Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin
R J Popert, J Goodall, M J Coptcoat, et al.
Biochemical Pharmacology
|
February 7, 1997
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl]mitomycin C). A new mitomycin C analogue activated by serum
J R Masters, R J Know, J A Hartley, et al.
Cancer Research
|
June 1, 1988
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines
P Bedford, A M Fichtinger-Schepman, S A Shellard, et al.
British Journal of Urology
|
December 1, 1985
Serum and tissue tumour markers in seminomas
T F Ford, D N Butcher, C T Samuell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1996
Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways
J R Masters, R Thomas, A G Hall, et al.
Chemico-Biological Interactions
|
January 1, 1987
Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II)
P Bedford, M C Walker, H L Sharma, et al.
International Journal of Oncology
|
March 24, 1999
Prognostic markers in clinically localised prostate cancer
X Z Bai, J R Masters, N O'Donoghue, et al.
Oncogene
|
May 9, 2007
Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer
Q Wang, M Williamson, S Bott, et al.
European Journal of Cancer
|
March 1, 1978
Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer
J R Masters, R A Hawkins, K Sangster, et al.
Page
of 11